Home > G. Tumoral pathology > FH–deficient pheochromocytoma
FH–deficient pheochromocytoma
Tuesday 23 August 2022
Fumarate Hydratase–deficient Pheochromocytoma and Paraganglioma
Definition : Up to 40% of pheochromocytomas (PCCs) and paragangliomas (PGLs) are hereditary. Germline mutations/deletions in fumarate hydratase (FH) cause hereditary leiomyomatosis and renal cell carcinoma syndrome which manifests predominantly with FH-deficient uterine/cutaneous leiomyomas and renal cell carcinomas (RCCs)—tumors characterized by loss of immunohistochemical (IHC) expression of FH and/or positive staining for S-(2-succino)-cysteine. Occasional patients develop PCC/PGL.
Paywall references
A Clinicopathologic and Molecular Analysis of Fumarate Hydratase–deficient Pheochromocytoma and Paraganglioma. doi : 10.1097/PAS.0000000000001945